Isomorphic Labs is putting AI-designed drugs into humans and the results will define a decade
Isomorphic Labs President Max Jaderberg confirmed at WIRED Health London that the company's AI-designed drug pipeline is heading to human trials, with ISM8969 already cleared by the FDA in January 2026.